Effects of fluvoxamine and fluoxetine on 5-HT1A and 5-HT2A receptors in mouse brain

Pharmacology Reviews and Communications

Volumn 12, Issue 4, 2002, Pages 215-221

  Hirano, Kazufumi ^a   Yamada, Shizuo ^a   Kimura, Ryohei ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

5 HT receptor binding; Fluoxetine; Fluvoxamine; Oral administration

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; FLUOXETINE; FLUVOXAMINE MALEATE; KETANSERIN; PAROXETINE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; TIME;

EID: 0036819394     PISSN: 10288945     EISSN: None     Source Type: Journal    
DOI: 10.1080/10604450214700     Document Type: Article

References (19)

1. 1A receptors. British Journal of Pharmacology, 130, 1348-1352.
2. Bosker F.J., Klompmakers A.A. and Westenberg H.G.M. (1995) Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology, 34, 501-508.
3. Figgitt D.P. and McClellan K.J. (2000) Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. Drugs, 60, 925-954.
4. 3H]paroxetine binding to rat cortical membranes. European Journal of Pharmacology, 118, 107-114.
5. Hirano K., Yamada S. and Kimura R. (2002) Brain serotonin transporter binding characteristics of fluvoxamine and fluoxetine. Pharmacology Reviews and Communications, 12, 129-137.
6. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R. and Humphrey P.A. (1994) Classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacological Reviews, 46, 157-203.
7. 1A-receptor subtype mediates the effects of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Folia Pharmacological Japonica, 68, 65-70.
8. 1B receptors. Journal of Pharmacology and Experimental Therapeutics, 292, 1111-1117.
9. Kulikov A., Aguerre S., Berton O., Ramos A., Mormede P. and Chaouloff F. (1997) Central serotonergic systems in the spontaneously hypertensive and lewis rat strains that differ in the elevated plus-maze test of anxiety. Journal of Pharmacology and Experimental Therapeutics, 281, 775-784.
10. Lowry O.H., Rosebrough N.J., Farr A.L. and Randall R.J. (1951) Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
11. Owens M.J., Morgan W.N., Plott S.J. and Nemeroff C.B. (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. Journal of Pharmacology and Experimental Therapeutics, 283, 1305-1322.
12. 3 receptors in the activity of antidepressants in the mouse forced swimming test. European Journal of Pharmacology, 325, 129-135.
13. Rosenthal H.E. (1967) Graphic method for the determination and presentation of binding parameters in a complex system. Analytical Biochemistry, 20, 525-532.
14. Rutter J.J. and Auerbach S.B. (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. Journal of Pharmacology and Experimental Therapeutics, 265, 1319-1324.
15. 1A receptors. European Journal of Pharmacology, 264, 241-247.
16. Schafer W.R. (1999) How do antidepressants work? Prospects for genetic analysis of drug mechanisms. Cell, 98, 551-554.
17. Stahl S.M. (1998) Mechanism of action of serotonin selective reuptake inhibitors serotonin receptors and pathways mediate therapeutic effects and side effects. Journal of Affective Disorders, 51, 215-235.
18. Wong D.T., Bymaster F.P. and Engleman E.A. (1995) Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sciences, 57, 411-441.
19. 3H]WB4101: Effect of 6-hydroxydopamine treatment. Journal of Pharmacology and Experimental Therapeutics, 215, 176-185.